CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.
January 2nd 2025
The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease.
December 30th 2024
December 13th 2024
Opdivo Alone, or Combined with Yervoy Shows Continued Survival Benefit in Advanced Skin Cancer
June 8th 2021More than six years of follow-up data show that Opdivo alone, or in combination with Yervoy, continued to induce long-term survival benefits compared to Yervoy alone in patients with previously untreated advanced skin cancer.
Novel TIL Therapy With Keytruda May Improve Treatment Responses in Advanced Skin Cancer
June 5th 2021Lifileucel with Keytruda may lead to an improved overall response rate of 86% for patients with advanced melanoma who were pre-checkpoint inhibitor naïve compared with those treated with Keytruda alone.
First-Line Opdivo-Novel Therapy Combo More Than Doubles Survival in Advanced Skin Cancer
May 20th 2021The use of Opdivo combined with the novel therapy relatlimab resulted in a significant improvement of progression-free survival compared to treatment with Opdivo, alone, in patients with previously untreated, unresectable or metastatic melanoma.
Effects of Keytruda Sustained After 3.5 Years in High-Risk Melanoma
April 23rd 2021In patients with resected high-risk stage 3 cutaneous melanoma, distant metastasis-free survival at 3.5 years was 65.3% in patients treated with Keytruda compared with 49.4% in those treated with placebo, which was also consistent in patients with PD-L1-positive tumors.
Indoor Tanning Won’t Cure Seasonal Affective Disorder
March 8th 2021As the winter months stretch on, those looking to treat Seasonal Affective Disorder (SAD) may be tempted to use indoor ultraviolet (UV) tanning devices. Not only is indoor tanning a dangerous habit, it does not successfully treat SAD.
Avastin Plus Chemotherapy Improves Progression-Free and Overall Survival in Mucosal Melanoma
January 27th 2021Avastin, in combination with carboplatin plus paclitaxel (types of chemotherapy), improved progression-free survival and overall survival compared with those who received chemotherapy alone for patients with untreated advanced mucosal melanoma.
Keytruda Continues to Show Sustained Survival Improvement in High-Risk Skin Cancer
November 6th 2020Patients with resected, high-risk, stage 3 melanoma who were randomized to receive Keytruda (pembrolizumab) achieved a three-year recurrence-free survival rate of 63.7% compared to 44.1% in patients randomized to placebo.
Adherence to Cholesterol-Lowering Drugs May Reduce Deaths From Cancer
November 3rd 2020Taking cholesterol-lowering drugs may provide a mortality benefit in women with newly diagnosed colorectal cancer, breast cancer and melanoma, although more research is needed to confirm this potential association.